Camille Granvil Selected Research

N- (3,4- difluoro- 2- (2- fluoro- 4- iodophenylamino)- 6- methoxyphenyl)- 1- (2,3- dihydroxypropyl)cyclopropane- 1- sulfonamide

12/2020	Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.
1/2020	Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Camille Granvil Research Topics

Disease

4	Neoplasms (Cancer) 12/2020 - 04/2014
2	Exanthema (Rash) 01/2020 - 05/2012
2	Diarrhea 01/2020 - 05/2012
2	Fatigue 01/2020 - 04/2014
2	Hypertension (High Blood Pressure) 01/2020 - 01/2020
2	Myalgia 04/2014 - 05/2012
1	Hyperglycemia 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Stomatitis 01/2020
1	Spasm (Spasms) 04/2014
1	Medulloblastoma 04/2014
1	Alopecia (Baldness) 04/2014
1	Dysgeusia (Parageusia) 04/2014
1	Basal Cell Carcinoma (Rodent Ulcer) 04/2014
1	Edema (Dropsy) 05/2012
1	Philadelphia Chromosome 05/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2012
1	Neutropenia 05/2012
1	Arthralgia (Joint Pain) 05/2012

Drug/Important Bio-Agent (IBA)

3	copanlisibIBA 12/2020 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2014
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2020 - 01/2020
2	N- (3,4- difluoro- 2- (2- fluoro- 4- iodophenylamino)- 6- methoxyphenyl)- 1- (2,3- dihydroxypropyl)cyclopropane- 1- sulfonamideIBA 12/2020 - 01/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020
1	Drug CombinationsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	EnzymesIBA 04/2014
1	sonidegibIBA 04/2014
1	Tyrosine Kinase InhibitorsIBA 05/2012
1	Imatinib Mesylate (Gleevec)FDA Link 05/2012
1	TOPSIBA 05/2012